Invention Grant
- Patent Title: Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof
-
Application No.: US17174006Application Date: 2021-02-11
-
Publication No.: US11649217B2Publication Date: 2023-05-16
- Inventor: Minhua Chen , Yanfeng Zhang , Jinqiu Wang , Xiaoyu Zhang
- Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
- Applicant Address: GB Brentford
- Assignee: GlaxoSmithKline Intellectual Property (NO.2) Limited
- Current Assignee: GlaxoSmithKline Intellectual Property (NO.2) Limited
- Current Assignee Address: GB Brentford
- Agent Nora L. Stein
- Priority: CN 1710835313.2 2017.09.15
- Main IPC: C07D239/62
- IPC: C07D239/62
Abstract:
The present disclosure relates to crystalline form CS1 and CS9 of a hypoxia-inducible factor prolyl hydroxylase inhibitor compound (I) GSK1278863, processes for preparation, and uses for preparing drugs treating and/or preventing anemia thereof.
Public/Granted literature
- US20210230124A1 CRYSTALLINE FORMS OF GSK1278863, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF Public/Granted day:2021-07-29
Information query
